Concepedia

Wouter J. C. van Ballegoij

WJ

6

Publications

301

Citations

6

H-Index

2018

Active since

Affiliations

Emma Kinderziekenhuis(Current)

Amsterdam University Medical Centers

University of Amsterdam

OLVG

University College London

Wouter J. C. van Ballegoij is an author at Emma Kinderziekenhuis specializing in clinical trials, disease progression, and medicine.

ORCID

Top concepts

Publications per year

2018–2023

6

Publications

6

International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy

Marc Engelen, Wouter J. C. van Ballegoij, Eric J. Mallack et al. · Neurology · 2022 · 128 citations · Full text

Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness

Irene C. Huffnagel, Wouter J. C. van Ballegoij, Björn M. van Geel et al. · Brain · 2018 · 60 citations · Full text

, , +11

Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial

Wolfgang Köhler, Marc Engelen, Florian Eichler et al. · The Lancet Neurology · 2023 · 38 citations · Full text

, , +6

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy

Wouter J. C. van Ballegoij, Stephanie I. W. van de Stadt, Irene C. Huffnagel et al. · Annals of Clinical and Translational Neurology · 2020 · 33 citations · Full text

Longitudinal diffusion MRI as surrogate outcome measure for myelopathy in adrenoleukodystrophy

Irene C. Huffnagel, Wouter J. C. van Ballegoij, Johanna M B W Vos et al. · Neurology · 2019 · 22 citations

Rows per page

1–5 of 6